Personal page of Jose Martínez-González
93 556 5896
Since 1993, Dr. Martínez-González has been studying vascular biology and the pathophysiological mechanisms of atherothrombosis. He has published more than 90 articles in scientific journals and specialized books.
Nowadays he leads the group of the Cardiovascular Research Center integrated in the Red Temática de Enfermedades Cardiovasculares (RECAVA, www.recava.com).
Research Interest: His research interests are centered on: 1) Analysis of the nuclear receptor NOR-1 in atherosclerosis, 2) Modulation of angiogenesis by hypoxia and pro-inflammatory and proatherogenic agents and 3) Identification and characterization of new biomarkers of ischemic cardiomyopathy.
- 2011
Angiotensin II differentially modulates cyclooxygenase-2, microsomal prostaglandin E2 synthase-1 and prostaglandin I2 synthase expression in adventitial fibroblasts exposed to inflammatory stimuli. - 2011
Hypoxia up-regulates PGI-synthase and increases PGI2 release in human vascular cells exposed to inflammatory stimuli. - 2010
Fibulin-5 is up-regulated by hypoxia in endothelial cells through A HIF-1{alpha} dependent mechanism. - 2010
New challenges for a second-generation low-molecular-weight heparin: focus on bemiparin. - 2010
Trans-10,cis-12-CLA dysregulate lipid and glucose metabolism and induce hepatic NR4A receptors.
-
Análisis funcional del receptor nuclear NOR-1 en la aterosclerosis e identificación de genes diana
Expression genes regulation involved in the vascular lesion. Regulation and functional genomic -
Bases moleculares de la aterosclerosis: análisis a nivel estructural del mecanismo de transactivación del receptor NOR-1
Expression genes regulation involved in the vascular lesion. Regulation and functional genomic -
Mecanismos implicados en el control de la homeostasis vascular por la Lisil Oxidasa
Expression genes regulation involved in the vascular lesion. Regulation and functional genomic -
Modulación de los efectos ateroprotectores de las HDL por las estatinas: regulación de la síntesis de prostaciclina en células vasculares a través de los receptores S1P
Molecular pathology of atherosclerosis illness -
NOR-1 y angiogénesis: análisis de los mecanismos de inducción y de la implicación de Neuron-derived Orphan Receptor-1 en la respuesta adaptativa de las células endoteliales a la hipoxia
Neovascularization impact in the pathological processes -
Red Cardiovascular - RECAVA
Cellular restructuring and cellular cardiomyoplasty -
Regulación de la función vascular por el receptor nuclear NOR-1: una nueva diana terapéutica para modular la enfermedad arterial coronaria
Diagnostic and prognostic markers of cardiovascular disease
Catalan Institute of Cardiovascular Sciences
Hospital de la Santa Creu i Sant Pau, Pavelló del Convent
Sant Antoni Maria Claret, 167 08025 Barcelona
Spain
T: +34 - 93 556 5900 F: +34 - 93 556 5559